Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
AstraZeneca
Merck
Medtronic
Moodys

Last Updated: August 17, 2022

Details for Patent: 8,168,614


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Which drugs does patent 8,168,614 protect, and when does it expire?

Patent 8,168,614 protects EUCRISA and is included in one NDA.

Protection for EUCRISA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has fifty-one patent family members in twenty-four countries.

Summary for Patent: 8,168,614
Title:Boron-containing small molecules as anti-inflammatory agents
Abstract: Methods of treating anti-inflammatory conditions through the use of boron-containing small molecules are disclosed.
Inventor(s): Baker; Stephen J. (Mountain View, CA), Sanders; Virginia (San Francisco, CA), Akama; Tsutomu (Sunnyvale, CA), Bellinger-Kawahara; Carolyn (Redwood City, CA), Freund; Yvonne (Los Altos, CA), Maples; Kirk R. (San Jose, CA), Plattner; Jacob J. (Berkeley, CA), Zhang; Yong-Kang (San Jose, CA), Zhou; Huchen (Shanghai, CN), Hernandez; Vincent S. (Watsonville, CA)
Assignee: Anacor Pharmaceuticals, Inc. (Palo Alto, CA)
Application Number:11/676,120
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,168,614
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation;

Drugs Protected by US Patent 8,168,614

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Anacor Pharms Inc EUCRISA crisaborole OINTMENT;TOPICAL 207695-001 Dec 14, 2016 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,168,614

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2007214421 See Plans and Pricing
Brazil PI0708051 See Plans and Pricing
Canada 2642583 See Plans and Pricing
Canada 2933994 See Plans and Pricing
China 101420854 See Plans and Pricing
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Harvard Business School
Express Scripts
Johnson and Johnson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.